| Ref ID | 915 |
| First Author | H. Yang |
| Journal | THE JOURNAL OF INTEGRATIVE MEDICINE |
| Year Of Publishing | 2023 |
| URL | https://www.sciencedirect.com/science/article/pii/S2095496422001261?via%3Dihub |
| Keywords |
• Gynaecology • Complimentary & Alternative • Transparency • Protocols • Low methodological quality • Disclosure • Pre-specification |
| Problem(s) |
• Individual study characteristics not reported sufficiently • Errors in study inclusion or omission of relevant studies • Poor consideration of publication bias • Reasons for excluding potentially eligible studies not provided • Conflicts of interest or funding of included studies not assessed • Financial conflicts of interest of review authors • No registered or published protocol |
| Article Type | Empirical |
| Article Subtype | Cross-sectional survey/Methodological systematic review |
| First Author Country | China |
| Aim | To summarize and evaluate the current evidence on the efficacy and safety of acupuncture for Polycystic ovary syndrome, as well as to assess the quality and risks of bias of the available Systematic Reviews. |
| Level of Investigation | Descriptive |
| Summary of Findings | From 11 included systematic reviews of acupuncture for Polycystic ovary syndrome indexed across nine electronic databases from inception to July 27 2022. Many of the included systematic reviews had deficiencies. Only 4 systematic reviews (36.36%) registered their protocol before the study began. Only 1 systematic review (9.09%) provided a list of excluded studies and justified the exclusions. Only 1 systematic review (9.09%) reported the sources of funding for the included RCTs. Only 2 systematic reviews (18.18%) examined the possibility of publication bias, and 6 systematic reviews (54.55%) stated no conflict of interest. There were 10 systematic reviews (90.91%) that had shortcomings, including incomplete retrieval and insufficiently detailed descriptions of the included randomised controlled trials. |
| Number of systematic reviews included | 11 |
| Number of eligible systematic reviews assessed | 739 |